2486 studies found for:    Pulmonary Disease, Chronic Obstructive
Show Display Options
Rank Status Study
21 Active, not recruiting Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Emphysema;   Bronchitis, Chronic
Intervention:
22 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate;   Drug: Anticholinergics
23 Completed
Has Results
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: 125/25 mcg once-daily GSK573719/GW642444;   Drug: 125mcg once-daily GSK573719;   Drug: Placebo once-daily
24 Completed Abdominal Functional Electrical Stimulation to Reduce Hyperinflation in Chronic Obstructive Pulmonary Disease Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: Abdominal Stimulation - low / early;   Device: Abdominal stimulation - low/late;   Device: Abdominal Stimulation - low/full;   Device: Abdominal stimulation - med/early;   Device: Abdominal stimulation - med/late;   Device: Abdominal Stimulation - med/full;   Device: Abdominal Stimulation - high/early;   Device: Abdominal Stimulation - high/late;   Device: Abdominal Stimulation - high/full
25 Active, not recruiting Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive;   Pulmonary Emphysema;   Bronchitis, Chronic;   Lung Diseases;   Disease Progression
Intervention:
26 Suspended High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Respiratory Insufficiency
Intervention: Device: Vapotherm High Flow Therapy
27 Completed
Has Results
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder;   Drug: FF Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo
28 Completed
Has Results
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo
29 Completed Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent®  inhalets
30 Completed
Has Results
Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol 250µg/50µg (FSC);   Drug: tiotropium bromide (TIO)
31 Completed Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® - inhalets
32 Completed Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804;   Drug: Placebo
33 Completed Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® inhalets
34 Completed Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® - inhalets
35 Recruiting Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Cognitive assessment
36 Completed Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Ventilat® - metered dose inhaler
37 Completed Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent®  Inhalation Solution
38 Completed Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Embolism;   Chronic Obstructive Pulmonary Disease
Intervention:
39 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS 250/50 mg BID;   Drug: SEREVENT 50 mcg BID
40 Not yet recruiting Resveratrol In Overweight Mild To Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)
Conditions: Pulmonary Disease, Chronic Obstructive;   Overweight
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years